Republican senator from South Carolina, Tim Scott, is a rising star in the party and a potential candidate for the GOP Presidential Nomination. He has raised the most money of any senator up for reelection in 2022, according to Federal Election Commission records.
He is a leader on efforts to bring opportunity to every American family, and he has been a driving force behind the creation of Opportunity Zones in the tax reform package passed in 2017. These zones help to stimulate economic growth in distressed communities across the country by creating tax incentives for businesses that invest in these areas.
In September, he introduced a resolution designating the month of September as Sickle Cell Disease Awareness Month to educate communities about sickle cell disease. The most common inherited blood disorder in the United States, sickle cell disease affects Black people disproportionately.
As a member of the Senate Finance Committee, Scott is a key player in legislation that can affect the drug industry. As such, he was the top recipient of pharma campaign cash in Congress during the second half of 2021, receiving $99,000, KHN’s Pharma Cash to Congress database shows.
While the pharma industry’s political contributions aren’t directly tied to specific legislative stances, they typically reflect the pharma’s belief that they have an important political role to play in a particular race. “They will sit at the beginning of a campaign and look at upcoming races to figure out who they want to help,” said Stephen Billet, an expert on political action committees and associate professor at the Graduate School of Political Management at George Washington University.